480 related articles for article (PubMed ID: 26169974)
1. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.
Fernandes BS; Steiner J; Bernstein HG; Dodd S; Pasco JA; Dean OM; Nardin P; Gonçalves CA; Berk M
Mol Psychiatry; 2016 Apr; 21(4):554-64. PubMed ID: 26169974
[TBL] [Abstract][Full Text] [Related]
2. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.
Fond G; Resseguier N; Schürhoff F; Godin O; Andrianarisoa M; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Leboyer M;
Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):541-553. PubMed ID: 29127503
[TBL] [Abstract][Full Text] [Related]
3. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications.
Fernandes BS; Steiner J; Berk M; Molendijk ML; Gonzalez-Pinto A; Turck CW; Nardin P; Gonçalves CA
Mol Psychiatry; 2015 Sep; 20(9):1108-19. PubMed ID: 25266124
[TBL] [Abstract][Full Text] [Related]
4. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia.
Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of C-reactive protein and IL-6 among the antipsychotic medicating schizophrenia patients of Siliguri, West Bengal, India.
Gurung J; Chamlagai D; Bera NK; Chaudhuri TK; Singh B
Nord J Psychiatry; 2018 May; 72(4):311-317. PubMed ID: 29464976
[TBL] [Abstract][Full Text] [Related]
6. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
[TBL] [Abstract][Full Text] [Related]
7. Association between C-reactive protein and risk of schizophrenia: An updated meta-analysis.
Wang Z; Li P; Chi D; Wu T; Mei Z; Cui G
Oncotarget; 2017 Sep; 8(43):75445-75454. PubMed ID: 29088880
[TBL] [Abstract][Full Text] [Related]
8. Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups.
Joseph J; Depp C; Martin AS; Daly RE; Glorioso DK; Palmer BW; Jeste DV
Schizophr Res; 2015 Oct; 168(1-2):456-60. PubMed ID: 26341579
[TBL] [Abstract][Full Text] [Related]
9. Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients.
Akanji AO; Ohaeri JU; Al-Shammri S; Fatania HR
Psychiatry Res; 2009 Aug; 169(1):56-61. PubMed ID: 19619902
[TBL] [Abstract][Full Text] [Related]
10. Increased high-sensitivity C-reactive protein levels in Taiwanese schizophrenic patients.
Lin CC; Chang CM; Liu CY; Huang TL
Asia Pac Psychiatry; 2013 Jun; 5(2):E58-63. PubMed ID: 23857813
[TBL] [Abstract][Full Text] [Related]
11. Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort.
Fond G; Godin O; Boyer L; Berna F; Andrianarisoa M; Coulon N; Brunel L; Bulzacka E; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Schürhoff F; Leboyer M;
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):985-992. PubMed ID: 29808267
[TBL] [Abstract][Full Text] [Related]
12. Correlation between brain damage, associated biomarkers, and medication in psychiatric inpatients: A cross-sectional study.
Yoshida M; Kanzaki T; Mizoi M; Nakamura M; Uemura T; Mimori S; Uju Y; Sekine K; Ishii Y; Yoshimi T; Yasui R; Yasukawa A; Sato M; Okamoto S; Hisaoka T; Miura M; Kusanishi S; Murakami K; Nakano C; Mizuta Y; Mishima S; Hayakawa T; Tsukada K; Kashiwagi K; Igarashi K
Clin Chim Acta; 2017 Jan; 464():50-56. PubMed ID: 27816667
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.
Fan X; Pristach C; Liu EY; Freudenreich O; Henderson DC; Goff DC
Psychiatry Res; 2007 Jan; 149(1-3):267-71. PubMed ID: 17112596
[TBL] [Abstract][Full Text] [Related]
14. Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment.
Steiner J; Frodl T; Schiltz K; Dobrowolny H; Jacobs R; Fernandes BS; Guest PC; Meyer-Lotz G; Borucki K; Bahn S; Bogerts B; Falkai P; Bernstein HG
Schizophr Bull; 2020 Feb; 46(2):363-373. PubMed ID: 31504969
[TBL] [Abstract][Full Text] [Related]
15. C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review.
Fond G; Lançon C; Auquier P; Boyer L
Front Psychiatry; 2018; 9():392. PubMed ID: 30190688
[No Abstract] [Full Text] [Related]
16. Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls.
Mohite S; Yang F; Amin PA; Zunta-Soares G; Colpo GD; Stertz L; Sharma AN; Fries GR; Walss-Bass C; Soares JC; Okusaga OO
PLoS One; 2017; 12(3):e0174073. PubMed ID: 28334045
[TBL] [Abstract][Full Text] [Related]
17. Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives.
Carrizo E; Fernández V; Quintero J; Connell L; Rodríguez Z; Mosquera M; Acosta A; Baptista T
Schizophr Res; 2008 Aug; 103(1-3):83-93. PubMed ID: 18436434
[TBL] [Abstract][Full Text] [Related]
18. Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.
Bulzacka E; Boyer L; Schürhoff F; Godin O; Berna F; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chéreau-Boudet I; Chesnoy-Servanin G; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Roux P; Yazbek H; Leboyer M; Fond G;
Schizophr Bull; 2016 Sep; 42(5):1290-302. PubMed ID: 27143795
[TBL] [Abstract][Full Text] [Related]
19. Uric acid levels in subjects with schizophrenia: A systematic review and meta-analysis.
He Q; You Y; Yu L; Yao L; Lu H; Zhou X; Wu S; Chen L; Chen Y; Zhao X
Psychiatry Res; 2020 Oct; 292():113305. PubMed ID: 32702552
[TBL] [Abstract][Full Text] [Related]
20. Association of high-sensitivity C-reactive protein with susceptibility to Schizophrenia in Tunisian population.
Ayari F; Ben Chaaben A; Ben Ammar H; Nefzi R; Ouni N; Mihoub O; Abaza H; Aissa A; Douik H; Gara S; Larnaout A; Salmi A; Ben Ammar-El Gaaied A; Leboyer M; El Hechmi Z; Guemira F; Tamouza R
Encephale; 2020 Aug; 46(4):241-247. PubMed ID: 31959465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
